News Dong Sung Bio Pharm.Co.,Ltd.

Equities

A002210

KR7002210003

End-of-day quote Korea S.E. Other stock markets 23:00:00 09/06/2024 BST			5-day change	1st Jan Change
5,020 ^KRW	-0.40%		-0.20%	-12.85%

2023	Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding	CI
2023	Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding	23/07/23	CI
Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding	19/07/23	CI
Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback announced on June 23, 2022, has expired.	22/09/22	CI
Tranche Update on Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback Plan announced on June 23, 2022.	24/08/22	CI
Dong Sung Bio Pharm.Co.,Ltd. announces an Equity Buyback for 261,780 shares.	23/06/22	CI
Dong Sung Bio Pharm.Co.,Ltd. authorizes a Buyback Plan.	22/06/22	CI
Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback announced on August 20, 2021, has expired.	18/11/21	CI
Tranche Update on Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback Plan announced on August 20, 2021.	07/10/21	CI
Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 8.5 billion in funding from a group of investors	22/08/21	CI
Dong Sung Bio Pharm.Co.,Ltd. announces an Equity Buyback for 209,424 shares.	20/08/21	CI
Dong Sung Bio Pharm.Co.,Ltd. authorizes a Buyback Plan.	19/08/21	CI
Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 8.5 billion in funding from a group of investors	12/08/21	CI
Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback announced on March 19, 2020, has expired.	18/06/20	CI
Tranche Update on Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback Plan announced on March 19, 2020.	21/04/20	CI
Dong Sung Bio Pharm.Co.,Ltd. announces an Equity Buyback for 233,918 shares.	19/03/20	CI
Dong Sung Bio Pharm.Co.,Ltd. authorizes a Buyback Plan.	18/03/20	CI
Dong Sung Bio Pharm.Co.,Ltd.(KOSE:A002210) added to S&P Global BMI Index	24/09/18	CI
Dongsung Pharmaceutical Co.,Ltd announced that it has received KRW 24 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm and other investors	15/04/18	CI
Dongsung Pharmaceutical Co.,Ltd announced that it expects to receive KRW 24 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm and other investors.	08/04/18	CI
Dongsung Pharmaceutical Co. Ltd. announced that it has received KRW 10 billion in funding from Synergy Partners Co., Ltd., Golden Bridge Asset Management Co., Ltd., Susung Asset Management Co., Ltd., NH Investment & Securities Co., Ltd., Investment Arm	11/07/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Dong Sung Bio Pharm.Co.,Ltd.

Equities

A002210

KR7002210003

Summary

Filters